A previous cross-sectional study has shown that NfL levels was associated with the markers of disease burden, cognition and disability in SVD.6 Cross-sectional analysis of our baseline data confirmed the results with NfL levels associating with the degree of cognitive impairment, of disability and markers of disease burden. This evidence concerns the gene NEFL and Cognitive impairment.